Endogenous endophthalmitis caused by salmonella serotype B in an immunocompetent 12-year-old child.
Aleksandra V
AV
Rachitskaya
Harry W
HW
Flynn
Janet L
JL
Davis
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005243:Feces / Q000382:microbiology; D006801:Humans; D007121:Immunocompetence; D008297:Male; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D010284:Paratyphoid Fever / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D012484:Salmonella paratyphi B / Q000302:isolation & purification*; D013845:Thienamycins / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use; D014792:Visual Acuity / Q000502:physiology; D014822:Vitreous Body / Q000382:microbiology
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D014640:Vancomycin; D002442:Ceftazidime; D000077731:Meropenem